KRAS-话题@MedSci

#KRAS#

77篇内容 | 4157人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1369023, encodeId=747f136902351, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=Medicine：帕尼单抗补充治疗可一定程度上改善WT KRAS的结直肠癌患者的客观反应，但会增加不良事件的发生率, objectType=article, longId=198620, objectId=2e5e19862046, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e5e19862046, replyNumber=0, likeNumber=73, createdTime=2020-08-04, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e5e19862046, moduleTitle=Medicine：帕尼单抗补充治疗可一定程度上改善WT KRAS的结直肠癌患者的客观反应，但会增加不良事件的发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e5e19862046)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1369022, encodeId=66b7136902233, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=NAT COMMUN：针对铜代谢杀死KRAS突变肿瘤, objectType=article, longId=198345, objectId=14b81983450d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14b81983450d, replyNumber=0, likeNumber=69, createdTime=2020-07-31, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14b81983450d, moduleTitle=NAT COMMUN：针对铜代谢杀死KRAS突变肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14b81983450d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1369021, encodeId=75a0136902151, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=PNAS：中山大学高国全团队发现，二甲双胍对KRAS突变型结直肠癌有效, objectType=article, longId=194988, objectId=4bc3194988c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bc3194988c4, replyNumber=0, likeNumber=74, createdTime=2020-06-01, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bc3194988c4, moduleTitle=PNAS：中山大学高国全团队发现，二甲双胍对KRAS突变型结直肠癌有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bc3194988c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1369020, encodeId=6535136902063, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=AACR 2020：KRAS新药用于NSCLC结果公布, objectType=article, longId=193182, objectId=863c19318287, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=863c19318287, replyNumber=0, likeNumber=0, createdTime=2020-05-01, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=863c19318287, moduleTitle=AACR 2020：KRAS新药用于NSCLC结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=863c19318287)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1369019, encodeId=bbbe13690191e, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=AACR 2020：KRAS突变在不同癌肿的发生率, objectType=article, longId=193176, objectId=cdb61931e68c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdb61931e68c, replyNumber=0, likeNumber=73, createdTime=2020-05-01, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdb61931e68c, moduleTitle=AACR 2020：KRAS突变在不同癌肿的发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cdb61931e68c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1369018, encodeId=caa5136901873, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=J Exp Clin Cancer Res：MAZ通过转录激活KRas依赖性的RalGEFs通路促进前列腺癌骨转移, objectType=article, longId=192934, objectId=0ff21929347b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ff21929347b, replyNumber=0, likeNumber=63, createdTime=2020-04-26, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ff21929347b, moduleTitle=J Exp Clin Cancer Res：MAZ通过转录激活KRas依赖性的RalGEFs通路促进前列腺癌骨转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ff21929347b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1369017, encodeId=e9f5136901e99, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=CELL REP：研究人员发现针对癌症KRAS突变的新疗法, objectType=article, longId=191876, objectId=d4601918e6f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4601918e6f6, replyNumber=0, likeNumber=80, createdTime=2020-04-11, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4601918e6f6, moduleTitle=CELL REP：研究人员发现针对癌症KRAS突变的新疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4601918e6f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1369016, encodeId=eb43136901604, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=KRAS突变靶向药物AMG510即将进入中国开展临床试验, objectType=article, longId=191150, objectId=311c19115003, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=311c19115003, replyNumber=0, likeNumber=80, createdTime=2020-04-01, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=311c19115003, moduleTitle=KRAS突变靶向药物AMG510即将进入中国开展临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=311c19115003)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1369015, encodeId=f91e1369015d3, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=PLK1抑制剂Onvasertib治疗KRAS突变的mCRC患者：肿瘤消退和临床获益, objectType=article, longId=186925, objectId=3f7618692587, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f7618692587, replyNumber=0, likeNumber=58, createdTime=2020-01-30, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f7618692587, moduleTitle=PLK1抑制剂Onvasertib治疗KRAS突变的mCRC患者：肿瘤消退和临床获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f7618692587)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1369014, encodeId=2c75136901495, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=Modern Pathology：反极性乳头状肾细胞癌中鉴定了复发性KRAS突变, objectType=article, longId=186807, objectId=d11a18680eac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d11a18680eac, replyNumber=0, likeNumber=87, createdTime=2020-01-29, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d11a18680eac, moduleTitle=Modern Pathology：反极性乳头状肾细胞癌中鉴定了复发性KRAS突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d11a18680eac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1369013, encodeId=d76d1369013be, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=KRAS药物进入爆发期, objectType=article, longId=183013, objectId=66c8183013e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66c8183013e0, replyNumber=0, likeNumber=81, createdTime=2019-11-16, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66c8183013e0, moduleTitle=KRAS药物进入爆发期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66c8183013e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1369012, encodeId=a9f813690128b, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=Nature：临床KRAS抑制剂AMG 510驱动抗肿瘤免疫, objectType=article, longId=182273, objectId=c5e61822e3a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5e61822e3a2, replyNumber=0, likeNumber=76, createdTime=2019-11-04, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5e61822e3a2, moduleTitle=Nature：临床KRAS抑制剂AMG 510驱动抗肿瘤免疫, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5e61822e3a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1369011, encodeId=bcc513690113e, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=Clinica Chimica Acta：利用改进的野生型阻断剂可在单管中敏感、选择性地检测密码子12和13 KRAS突变, objectType=article, longId=179432, objectId=0a3e1e94321f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a3e1e94321f, replyNumber=0, likeNumber=80, createdTime=2019-09-15, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a3e1e94321f, moduleTitle=Clinica Chimica Acta：利用改进的野生型阻断剂可在单管中敏感、选择性地检测密码子12和13 KRAS突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a3e1e94321f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1369010, encodeId=59c91369010db, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=WCLC 2019：KRAS抑制剂AMG 510显著缩小了NSCLC患者的肿瘤, objectType=article, longId=179175, objectId=f41b1e9175df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f41b1e9175df, replyNumber=0, likeNumber=66, createdTime=2019-09-10, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f41b1e9175df, moduleTitle=WCLC 2019：KRAS抑制剂AMG 510显著缩小了NSCLC患者的肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f41b1e9175df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1369009, encodeId=b0bc1369009d6, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=针对KRAS突变驱动的癌症疫苗, objectType=article, longId=177310, objectId=f1711e73100d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1711e73100d, replyNumber=0, likeNumber=66, createdTime=2019-08-10, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1711e73100d, moduleTitle=针对KRAS突变驱动的癌症疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1711e73100d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1369008, encodeId=4a47136900889, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=Amgen的AMG 510在KRAS突变的非小细胞肺癌I期临床实现突破, objectType=article, longId=167693, objectId=bf9916e693b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf9916e693b0, replyNumber=0, likeNumber=90, createdTime=2019-06-06, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf9916e693b0, moduleTitle=Amgen的AMG 510在KRAS突变的非小细胞肺癌I期临床实现突破, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf9916e693b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1369007, encodeId=5f3e136900e0d, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=Life Sci：KRas-ERK1 / 2信号的激活通过抑制赖氨酸16处组蛋白H4的乙酰化来驱动胶质瘤的发生发展, objectType=article, longId=164838, objectId=ba371648384b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba371648384b, replyNumber=0, likeNumber=70, createdTime=2019-04-24, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba371648384b, moduleTitle=Life Sci：KRas-ERK1 / 2信号的激活通过抑制赖氨酸16处组蛋白H4的乙酰化来驱动胶质瘤的发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba371648384b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1369006, encodeId=54a013690062a, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=Cell Metab:糖真的有毒！高血糖环境下，胰腺细胞中致癌的KRAS突变暴增，或为导致胰腺癌的罪魁祸首之一, objectType=article, longId=163057, objectId=c6f416305ec3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6f416305ec3, replyNumber=0, likeNumber=61, createdTime=2019-03-28, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6f416305ec3, moduleTitle=Cell Metab:糖真的有毒！高血糖环境下，胰腺细胞中致癌的KRAS突变暴增，或为导致胰腺癌的罪魁祸首之一, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6f416305ec3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1369005, encodeId=2f9c136900529, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=Sci Transl Med:KRAS突变型肺癌或喜迎MEK抑制剂联合用药, objectType=article, longId=162939, objectId=156a1629396a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=156a1629396a, replyNumber=0, likeNumber=82, createdTime=2019-03-26, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=156a1629396a, moduleTitle=Sci Transl Med:KRAS突变型肺癌或喜迎MEK抑制剂联合用药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=156a1629396a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1369004, encodeId=675513690045e, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=JTO：病例分享——见微知著，KRAS突变肺腺癌转化为小细胞肺癌是免疫治疗的耐药机制？, objectType=article, longId=159865, objectId=7f2d1598656e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f2d1598656e, replyNumber=0, likeNumber=83, createdTime=2019-02-14, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f2d1598656e, moduleTitle=JTO：病例分享——见微知著，KRAS突变肺腺癌转化为小细胞肺癌是免疫治疗的耐药机制？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f2d1598656e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

KRAS

2020-05-29

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

Medicine：帕尼单抗补充治疗可一定程度上改善WT KRAS的结直肠癌患者的客观反应，但会增加不良事件的发生率

2020-08-04

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

NAT COMMUN：针对铜代谢杀死KRAS突变肿瘤

2020-07-31

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

PNAS：中山大学高国全团队发现，二甲双胍对KRAS突变型结直肠癌有效

2020-06-01

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

AACR 2020：KRAS新药用于NSCLC结果公布

2020-05-01

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

AACR 2020：KRAS突变在不同癌肿的发生率

2020-05-01

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

J Exp Clin Cancer Res：MAZ通过转录激活KRas依赖性的RalGEFs通路促进前列腺癌骨转移

2020-04-26

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

CELL REP：研究人员发现针对癌症KRAS突变的新疗法

2020-04-11

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

KRAS突变靶向药物AMG510即将进入中国开展临床试验

2020-04-01

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

PLK1抑制剂Onvasertib治疗KRAS突变的mCRC患者：肿瘤消退和临床获益

2020-01-30

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

Modern Pathology：反极性乳头状肾细胞癌中鉴定了复发性KRAS突变

2020-01-29

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

KRAS药物进入爆发期

2019-11-16

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

Nature：临床KRAS抑制剂AMG 510驱动抗肿瘤免疫

2019-11-04

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

Clinica Chimica Acta：利用改进的野生型阻断剂可在单管中敏感、选择性地检测密码子12和13 KRAS突变

2019-09-15

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

WCLC 2019：KRAS抑制剂AMG 510显著缩小了NSCLC患者的肿瘤

2019-09-10

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

针对KRAS突变驱动的癌症疫苗

2019-08-10

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

Amgen的AMG 510在KRAS突变的非小细胞肺癌I期临床实现突破

2019-06-06

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

Life Sci：KRas-ERK1 / 2信号的激活通过抑制赖氨酸16处组蛋白H4的乙酰化来驱动胶质瘤的发生发展

2019-04-24

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

Cell Metab:糖真的有毒！高血糖环境下，胰腺细胞中致癌的KRAS突变暴增，或为导致胰腺癌的罪魁祸首之一

2019-03-28

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

Sci Transl Med:KRAS突变型肺癌或喜迎MEK抑制剂联合用药

2019-03-26

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

JTO：病例分享——见微知著，KRAS突变肺腺癌转化为小细胞肺癌是免疫治疗的耐药机制？

2019-02-14

科室
- - 订阅+
  - 更多科室
工具
服务